We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
(-31%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-16.3%
Top 10 Holdings %
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$146M |
| 2 |
Linde
LIN
|
+$117M |
| 3 |
Visa
V
|
+$108M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$106M |
| 5 |
Stanley Black & Decker
SWK
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$173M |
| 2 |
eBay
EBAY
|
+$149M |
| 3 |
Zoetis
ZTS
|
+$127M |
| 4 |
Teleflex
TFX
|
+$108M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$98.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.96% |
| 2 | Consumer Discretionary | 18.46% |
| 3 | Technology | 13.47% |
| 4 | Financials | 11.57% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVET
1251
DELISTED
Covetrus, Inc. Common Stock
CVET
| $145K | ﹤0.01% |
+17,790
| New | +$203K |
|
1252
Nexstar Media Group
NXST
$5.92B
| $144K | ﹤0.01% |
2,501
-53,702
| -96% | -$5.68M |
|
1253
BioCryst Pharmaceuticals
BCRX
$2.48B
| $143K | ﹤0.01% |
+71,660
| New | +$197K |
|
1254
Energizer
ENR
$1.5B
| $143K | ﹤0.01% |
+4,726
| New | +$214K |
|
|
VIOT
1255
Viomi Technology
VIOT
$50.5M
| $143K | ﹤0.01% |
32,873
-78,745
| -71% | -$533K |
|
1256
BHP
BHP
$213B
| $141K | ﹤0.01% |
4,304
+986
| +30% | +$41.2K |
|
1257
FB Financial Corp
FBK
$2.98B
| $141K | ﹤0.01% |
+7,163
| New | +$229K |
|
|
KALV
1258
DELISTED
KalVista Pharmaceuticals
KALV
| $141K | ﹤0.01% |
+18,454
| New | +$249K |
|
|
RYZ
1259
Ryerson Holding Corp
RYZ
$1.61B
| $139K | ﹤0.01% |
+26,216
| New | +$231K |
|
1260
Colgate-Palmolive
CL
$74.2B
| $138K | ﹤0.01% |
2,086
-97,914
| -98% | -$6.91M |
|
1261
iShares MSCI Italy ETF
EWI
$993M
| $138K | ﹤0.01% |
6,633
-42,418
| -86% | -$1.13M |
|
|
AGEN
1262
Agenus
AGEN
$275M
| $137K | ﹤0.01% |
+2,855
| New | +$179K |
|
1263
Equinix
EQIX
$102B
| $137K | ﹤0.01% |
+220
| New | +$132K |
|
|
LTC
1264
LTC Properties
LTC
$2.14B
| $136K | ﹤0.01% |
+4,405
| New | +$188K |
|
1265
Texas Pacific Land
TPL
$26.9B
| $135K | ﹤0.01% |
+3,204
| New | +$235K |
|
1266
US Bancorp
USB
$100B
| $135K | ﹤0.01% |
+3,912
| New | +$189K |
|
1267
Prologis
PLD
$137B
| $134K | ﹤0.01% |
1,662
-12,455
| -88% | -$1.09M |
|
1268
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
| $134K | ﹤0.01% |
9,234
-991,638
| -99% | -$23.5M |
|
1269
SITE Centers
SITC
$235M
| $133K | ﹤0.01% |
32,644
+3,701
| +13% | +$32.1K |
|
1270
ING
ING
$95.1B
| $132K | ﹤0.01% |
25,544
+18,861
| +282% | +$182K |
|
1271
Biglari Holdings Class B
BH
$1.18B
| $130K | ﹤0.01% |
2,524
+1,496
| +146% | +$147K |
|
1272
Pediatrix Medical
MD
$2.21B
| $130K | ﹤0.01% |
11,149
-31,001
| -74% | -$639K |
|
1273
KALA BIO
KALA
$12.3M
| $129K | ﹤0.01% |
+6
| New | +$95.9K |
|
1274
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
| $129K | ﹤0.01% |
+3,017
| New | +$162K |
|
|
NTCO
1275
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $128K | ﹤0.01% |
+13,048
| New | +$242K |
|
Similar funds
Marshall Wace's Q1 2020 Portfolio in Review
As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.
- Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
- Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
- Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
- Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
- Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
- Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.
Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.